Previous Article | Next Article ![]()
Infection and Immunity, October 2004, p. 6160-6163, Vol. 72, No. 10
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.10.6160-6163.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, Quebec City, Quebec, Canada
Received 25 April 2004/ Returned for modification 1 June 2004/ Accepted 7 July 2004
|
|
|---|
|
|
|---|
Previous studies have shown that cell surface receptors of several bacterial pathogens can bind the 90-kDa plasma proenzyme plasminogen, which can be subsequently activated into plasmin, a broad-spectrum serine protease (7). In this study, we hypothesized that, like plasminogen, pro-MMPs could bind to the cell surface of bacteria, thus allowing them to acquire a proteolytic activity. To our knowledge, such a phenomenon has never been reported in the literature. Binding of pro-MMPs by periodontopathogens could increase tissue damage and promote their capacity to invade host tissues and disseminate to cause focal infections. The aim of our study was thus to investigate the binding and activation of human pro-MMP-9 on the cell surface of the periodontopathogenic bacterial species Fusobacterium nucleatum. The potential role of this acquired proteolytic activity in tissue invasion and destruction was evaluated using a reconstituted basement membrane (Matrigel).
Three subspecies of F. nucleatum (F. nucleatum subsp. nucleatum ATCC 25586 [isolated from human inflamed gingiva], F. nucleatum subsp. vincentii ATCC 49256 [isolated from human periodontal pocket], and F. nucleatum subsp. polymorphum ATCC 10953 [isolated from human cervico-facial lesion]) were grown in Todd-Hewitt broth (BBL Microbiology Systems, Cockeysville, Md.) at 37°C for 24 h under anaerobic conditions (N2/H2/CO2, 80:10:10). Cells were harvested by centrifugation (10,000 x g for 10 min) and suspended in 50 mM phosphate-buffered saline (PBS), pH 7.2, to an optical density at 660 nm of 1.0. This corresponded to a concentration of 1 x 109 bacteria/ml as determined by using a Petroff-Hausser counting chamber. The capacity of fusobacteria to bind human pro-MMP-9 was evaluated by an enzyme-linked immunosorbent assay (ELISA). One hundred microliters of the bacterial suspension was added to the wells of a microtiter plate (Nunc Maxisorp, Roskilde, Denmark), and bacteria were allowed to attach for 16 h at 37°C in a humid atmosphere. The liquid phase was then discarded and the wells were washed three times with PBS prior to fixing bacteria by adding 0.05% (vol/vol) glutaraldehyde for 30 min. The wells were again washed three times with PBS prior to blocking unreacted sites with 3% gelatin for 1 h. Human pro-MMP-9 (2 µg/100 µl; Oncogene, Cambridge, Mass.) was added to wells containing bacterial layers, and the plate was incubated for 2 h at room temperature. The wells were extensively washed three times with PBS prior to adding sheep anti-MMP-9 antibody (1:500; Biodesign, Kennebunk, Maine) as the first antibody (1 h) and then rabbit anti-sheep immunoglobulin G conjugated to alkaline phosphatase (1:5,000; Bethyl Laboratories, Montgomery, Tex.) as the second antibody (1 h). Three washings with 50 mM Tris hydrochloride buffer (pH 7.2) containing 0.05% Tween 20 were performed after the incubation with each antibody. A negative control in which wells were covered with 3% gelatin instead of bacteria was performed. An additional control was carried out by omitting the incubation step of bacteria with pro-MMP-9. The enzymatic reaction was revealed in 50 mM carbonate buffer (pH 9.8) containing p-nitrophenylphosphate, and the absorbance was measured at 405 nm after a 2-h incubation. Binding of p-aminophenylmercuric acetate (APMA; 0.5 mM)-activated MMP-9 was also tested. Binding assays performed in the presence of polymyxin B (1 mM) or the lysine analog
-aminocaproic acid (10 mM) were also done. The means ± standard deviations of three independent experiments were calculated for all the binding assays. A standard curve in which increasing amounts of pro-MMP-9 (3.2, 16, 80, and 400 ng) were immobilized on the bottoms of the wells was constructed to estimate the amount of pro-MMP-9 bound to the fusobacteria. All three subspecies of F. nucleatum tested in the ELISA bound pro-MMP-9. From the standard curve, the relative amounts of pro-MMP-9 bound by F. nucleatum subsp. nucleatum, F. nucleatum subsp. vincentii, and F. nucleatum subsp. polymorphum were estimated at 144 ± 31, 103 ± 51, and 96 ± 28 ng, respectively. These quantities were bound by 2 x 107 cells, since approximately 20% of the initial quantity of cells added into a well attached to the bottom of the well (data not shown). When the pro-MMP-9 was activated with APMA prior to the binding assay, comparable binding levels were obtained. No binding of pro-MMP-9 to gelatin-coated wells was observed. F. nucleatum subsp. nucleatum, which tends to bind pro-MMP-9 more efficiently than the two other subspecies, was chosen for subsequent analysis. The lysine analog
-aminocaproic acid did not reduce the amount of pro-MMP-9 bound by the fusobacteria, thus suggesting that the plasminogen receptor previously reported (3) is not involved in binding of pro-MMP-9. Furthermore, the addition of polymyxin B, a lipid A-binding substance, did not reduce binding, suggesting that lipopolysaccharide is not involved.
The conversion of pro-MMP-9 bound to fusobacteria into a proteolytically active form was then investigated. The F. nucleatum subsp. nucleatum cell suspension was incubated with pro-MMP-9 (0.14 ng/µl) for 2 h at room temperature with gentle shaking. The cells were then washed three times in PBS by centrifugation at 10,000 x g for 10 min and suspended in the original volume of PBS. The pro-MMP-9 bound to the bacteria was activated by adding 0.5 mM APMA to the cell suspension. After a 30-min incubation, the cell-associated gelatinase activity was revealed by zymography on a 10% polyacrylamide gel containing 0.5% gelatin as previously described (4). Zymography revealed the presence of bands with gelatinase activity only with fusobacteria that had been incubated with pro-MMP-9 (Fig. 1A). Bands with a molecular mass corresponding to pro-MMP-9 (92 kDa) and to the predominant active forms of MMP-9 (82 and 65 kDa) were detected when pro-MMP-9-coated cells were treated with APMA. A colorimetric gelatinase assay (Boehringer Mannheim Canada, Laval, Quebec, Canada) was also used to confirm the acquisition of proteolytic activity by F. nucleatum subsp. nucleatum. In this assay, cells were incubated with biotin-labeled gelatin prior to measuring gelatinase activity in a streptavidin-coated microtiter plate according to the manufacturer's instructions. High gelatinase activity yielded a low signal as determined by the absorbance at 405 nm. Bacteria coated with pro-MMP-9 and subsequently treated with APMA had significant gelatinase activity compared to control cells (uncoated or coated with pro-MMP-9 without activation) (Fig. 1B).
![]() View larger version (20K): [in a new window] |
FIG. 1. Gelatinase activity of F. nucleatum subsp. nucleatum ATCC 25586 following various treatments. (A) Analysis by zymography on gelatin-containing polyacrylamide gel. (B) Analysis by a colorimetric assay using biotin-labeled gelatin and for which a high gelatinase activity yields a low signal determined by measuring the absorbance at 405 nm. Lanes and columns: 1, APMA-activated pro-MMP-9 control; 2, bacteria coated with pro-MMP-9 subsequently activated with APMA; 3, bacteria coated with pro-MMP-9 without activation; 4, control uncoated bacteria. The asterisk indicates a significant difference between cells coated with APMA-activated pro-MMP-9 and control uncoated cells at a P value of < 0.005, determined by using a two-tailed Student's t test.
|
![]() View larger version (8K): [in a new window] |
FIG. 2. Penetration of a reconstituted basement membrane (Matrigel) by F. nucleatum subsp. nucleatum ATCC 25586 under various conditions. Columns: 1, bacteria coated with APMA-activated pro-MMP-9; 2, bacteria (1/10 the amount applied in column 1) coated with APMA-activated pro-MMP-9; 3, control uncoated bacteria; 4, bacteria coated with APMA-activated pro-MMP-9 plus 1 mM EDTA; 5, bacteria coated with APMA-activated pro-MMP-9 and treated at 60°C for 30 min. After an incubation of 2 (left panel), and 4 h (right panel), radioactivity in the buffer present in the lower well was determined and used to estimate the number of cells that migrated through Matrigel. The values are the means ± standard deviations of three independent assays. The asterisk indicates differences between cells coated with APMA-activated pro-MMP-9 and control uncoated cells at P < 0.005, determined by using a two-tailed Student's t test.
|
-aminocaproic acid, which is known to inhibit the binding of plasminogen to F. nucleatum subsp. nucleatum (3), had no inhibitory effect. This suggests that different receptors on F. nucleatum subsp. nucleatum are responsible for the binding of plasminogen and pro-MMP-9. MMP-9 is known to possess a fibronectin-like sequence and a collagen-like domain (13). Interestingly, F. nucleatum cells attach to fibronectin and to a basement-like matrix (15). Also, pro-MMP-8, which does not possess a fibronectin-like sequence or collagen-like domain, was not bound by F. nucleatum subsp. nucleatum in the ELISA (data not shown). MMPs, including MMP-9, are thought to play an important role in tissue destruction during periodontitis (10). Bacterial pathogens in the periodontal pocket may increase their virulence by taking advantage of their capacity to bind host-derived proteolytic enzymes such as MMPs. We have clearly demonstrated that pro-MMP-9 bound to F. nucleatum subsp. nucleatum could be activated to generate gelatinase activity on the cell surface of this bacterial species, which is normally a nonproteolytic bacterium. Furthermore, fusobacteria coated with active MMP-9 were more invasive than control bacteria in a basement membrane model. Given that periodontal pockets contain elevated levels of MMPs and their endogenous activators (10, 14), it is possible that in vivo, MMPs may be bound by F. nucleatum and be subsequently activated. The ability of F. nucleatum to acquire MMP activity could facilitate bacterial dissemination to surrounding periodontal tissues and blood vessels. Interestingly, MMP-9 has been reported to process interleukin-1ß from its precursor form to an active form (12). The MMP-9 bound to F. nucleatum subsp. nucleatum may thus be involved in the regulation of the activity of cytokines, more particularly interleukin-1ß, which plays a central role in acute and chronic inflammation.
Recent studies have suggested relationships between periodontitis and a number of systemic diseases and conditions, including cardiovascular diseases, respiratory tract infections, and premature births of low-weight babies (8). More particularly, there is an association between Fusobacterium infections in intact amniotic membranes and premature births (5, 11). F. nucleatum is isolated more frequently in amniotic fluid in women who give birth prematurely than any other bacteria (5). One of the hypotheses proposed to explain the presence of this bacterial species is that F. nucleatum migrates from other distant infection sites, such as the uterine cervix and the oral cavity. In fact, the species and subspecies isolated from amniotic fluid, including F. nucleatum subsp. vincentii and F. nucleatum subsp. nucleatum, are similar to those encountered in healthy and diseased subgingival sites, unlike the strains isolated from the inferior genital tract (5, 6). The capacity of F. nucleatum subsp. nucleatum to acquire MMP-9 activity may contribute to its capacity to migrate through tissues and cause focal infections.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»